Technical Analysis for ACAD - ACADIA Pharmaceuticals Inc.
|Grade||Last Price||% Change||Price Change|
ACAD closed down 0.11 percent on Friday, September 22, 2017, on 62 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Trend Table & Recent Alerts
|See historical ACAD trend table...|
|Date||Alert Name||Type||% Chg|
|Sep 22||Stochastic Reached Overbought||Other||0.00%|
|Sep 19||MACD Bearish Signal Line Cross||Bearish||2.85%|
|Sep 15||Golden Cross||Bullish||2.06%|
|Sep 15||Non-ADX 1,2,3,4 Bullish||Bullish Swing Setup||2.06%|
|Sep 14||NR7||Range Contraction||3.35%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. The company has a pipeline of product candidates led by pimavanserin, which is in Phase III development stage for the treatment of Parkinson's disease psychosis. It is also developing pimavanserin that has completed Phase II co-therapy trials for the treatment of schizophrenia; and is in Phase II clinical trials for the treatment of Alzheimer's disease psychosis. In addition, the company, through collaboration with Allergan, Inc., is developing alpha adrenergic agonists, which are in Phase II clinical trials for the treatment of chronic pain; and muscarinic agonist that is in Phase I clinical trials for the treatment of glaucoma. Further, it is developing two advanced preclinical programs directed at Parkinson's disease and other neurological disorders. The company was formerly known as Receptor Technologies, Inc. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Is ACAD a Buy, Sell or Hold?
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more ACAD news...
|52 Week High||40.83|
|52 Week Low||20.68|
|200-Day Moving Average||31.9435|
|50-Day Moving Average||32.6806|
|20-Day Moving Average||35.971|
|10-Day Moving Average||36.951|
|Average True Range||1.0927|
|Chandelier Exit (Long, 3 ATRs)||34.7519|
|Chandelier Exit (Short, 3 ATRs)||34.4181|
|Upper Bollinger Band||38.7172|
|Lower Bollinger Band||33.2248|
|Percent B (%b)||0.79|
|MACD Signal Line||1.4563|